MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

MSL Pharma (Met Syn Lysine Ltd).
MSL Pharma (Met Syn Lysine Ltd).

50% of overweight & obese individuals suffer from Metabolic Syndrome in which there is a chronic elevation of blood Insulin levels, which in turn increases Insulin Resistance, causing an increase in appetite and over-eating, thus creating a vicious cycle, causing MI & Strokes.
We will cut off this vicious cycle by inhibiting Insulin secretion using a Somatostatin analogue, reverse Metabolic Syndrome, lower body weight & prevent pre-diabetic patients from developing type 2 diabetes.
A cyclic oral Somatostatin analogue to reverse Metabolic Syndrome will lower weight, blood sugar, blood pressure & balance blood lipids

Connect with MSL Pharma (Met Syn Lysine Ltd).


2020 Finalist Israel

Sub industry

Therapeutics (Pharma / Biotech)


Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.